The ischemic activation of p38␣ mitogen-activated protein kinase (p38␣-MAPK) is thought to contribute to myocardial injury. Under other circumstances, activation is through dual phosphorylation by MAPK kinase 3 (MKK3). Therefore, the mkk3 Ϫ/Ϫ murine heart should be protected during ischemia. In retrogradely perfused mkk3 Ϫ/Ϫ and mkk3 ϩ/ϩ mouse hearts subjected to 30 minutes of global ischemia and 120 minutes of reperfusion, infarction/risk volume was similar (50Ϯ5 versus 51Ϯ4, Pϭ0.93, respectively), as was intraischemic p38-MAPK phosphorylation (10 minutes ischemia as percent basal, 608Ϯ224 versus 384Ϯ104, Pϭ0.43, respectively). This occurred despite undetectable activation of MKK3/6 in mkk3 Ϫ/Ϫ hearts. However, tumor necrosis factor (TNF)-induced p38-MAPK phosphorylation was markedly diminished in mkk3 Ϫ/Ϫ vs mkk3 ϩ/ϩ hearts (percent basal, 127Ϯ23 versus 540Ϯ267, respectively, Pϭ0.04), suggesting an MKK-independent activation mechanism by ischemia. Hence, we examined p38-MAPK activation by TAB1-associated autophosphorylation. In wild-type mice and mkk3 Ϫ/Ϫ mice, the p38-MAPK catalytic site inhibitor SB203580 (1 mol/L) diminished phosphorylation during ischemia versus control (10 minutes ischemia as percent basal, 143Ϯ2 versus 436Ϯ96, Pϭ0.003, and 122Ϯ25 versus 623Ϯ176, Pϭ0.05, respectively) and reduced infarction volume (infarction/risk volume, 57Ϯ5 versus 36Ϯ3, PϽ0.001, and 50Ϯ5 versus 29Ϯ3, Pϭ0.003, respectively) but did not alter TNF-induced activation, although in homogenates of ischemic hearts but not TNF-exposed hearts, p38-MAPK was associated with TAB1. Furthermore, adenovirally expressed wild-type and drug-resistant p38␣-MAPK, lacking the SB203580 binding site, was phosphorylated when H9c2 myoblasts were subjected to simulated ischemia. However, SB203580 (1 mol/L) did not prevent the phosphorylation of resistant p38␣-MAPK. These findings suggest the ischemic activation of p38-MAPK contributing to myocardial injury is by TAB1-associated autophosphorylation. (Circ Res. 2003;93:254-261.) Key Words: p38 mitogen-activated protein kinase Ⅲ myocardial infarction Ⅲ TAB1 Ⅲ ischemic preconditioning Ⅲ mitogen-activated protein kinase kinase 3
R ecent attention has focused on myocardial p38 mitogen-activated protein kinase (p38-MAPK) as a critical determinant of myocardial injury during ischemia and reperfusion. 1 In the absence of preconditioning, most investigators find that the activation of p38-MAPK that accompanies true and simulated ischemia/reperfusion contributes to injury. [2] [3] [4] [5] [6] [7] [8] [9] Previously, using a variety of approaches, we have shown that the p38␣-MAPK isoform becomes activated and increases cell death during simulated ischemia in cell lines and in adult and neonatal primary cardiocytes. 1, 3 Using one of these models, Wang et al 10 have shown that the upstream kinase, mitogen-activated protein kinase kinase-3 (MKK3), preferentially activates p38␣-MAPK by dual phosphorylation and increases cell death. This observation is in keeping with mutational analyses of MKK3 that have mapped the regions within its primary sequence responsible for this preference 11 and with the resolved structure of p38␣-MAPK bound to a peptide fragment of MKK3. 12 In addition, using an organ-specific conditional transgenic approach, Wang and colleagues 13 have shown that MKK3 activates p38-MAPK in murine myocardium where p38␣-MAPK is the only isoform detected. Furthermore, even in the absence of ischemia, such activation leads to myocyte death and cardiomyopathy. 13 Thus, p38␣-MAPK is activated by MKK3, and its activation contributes to injury.
Based on these observations, we hypothesized that ischemia/reperfusion injury would be attenuated in murine hearts lacking MKK3. In this study we show that this hypothesis is untenable, because phosphorylation of the key Thr 180 and Tyr 182 residues within the activation lip are not diminished in MKK3-deficient hearts during ischemia. We show instead that under these circumstances the phosphorylation of these residues is inhibited by the p38-MAPK catalytic site inhibitor SB203580, suggesting autophosphorylation. This suggestion is consistent with the inability of SB203580 to inhibit the ischemia-induced phosphorylation of p38␣-MAPK in which the SB-binding residues are mutated. Furthermore, inhibiting ischemia-induced phosphorylation of p38-MAPK reduces infarction volume. Under this circumstance, p38-MAPK is found associated with TAB1. This pattern contrasts with the activation of myocardial p38-MAPK by tumor necrosis factor (TNF), which is MKK3-dependent but SB203580-and TAB1-independent.
Materials and Methods
All experiments were performed in accordance with United Kingdom Home Office Guidance on the Operation of Animals (Scientific Procedures) Act 1986, published by Her Majesty's Stationary Office, London.
MKK3-Deficient Mice
The targeting strategy used to generate the mkk3 Ϫ/Ϫ mice has been described previously. 14 A colony was rederived from this source by crossing an mkk3 Ϫ/Ϫ male to an outbred C57B/6 female. For the purposes of this study, to reduce background genetic variability, we used male mkk3 Ϫ/Ϫ and mkk3 ϩ/ϩ progeny of heterozygote matings, which whenever possible were littermates.
Perfusion of Isolated Murine Hearts
Male mice were anesthetized with pentobarbital (300 mg/kg with 150 IU heparin, IP). Hearts were rapidly excised, placed in ice-cold modified Krebs-Henseleit (K-H) buffer containing (in mmol/L) NaCl 118.5, NaHCO 3 25.0, KCl 4.75, KH 2 PO 4 1.18, MgSO 4 1.19, D-glucose 11.0, and CaCl 2 1.41. The aorta was cannulated and retrogradely perfused at a constant pressure of 80 mm Hg with K-H buffer equilibrated with 95% O 2 and 5% CO 2 . After perfusion, the heart temperature was monitored continuously by a K-type thermocouple passed retrogradely through the pulmonary valve into the right ventricle. The temperature was maintained at 37Ϯ0.3 C°by immersing the heart in K-H in a water-jacketed chamber. A fluidfilled balloon inserted into the left ventricle monitored contractile function. The balloon was gradually inflated until the end-diastolic pressure was between 3 and 7 mm Hg. Hearts were then paced at 580 bpm with a 0.075-mm silver wire (Advent) placed through the right ventricular wall into the right ventricular apex. The wire and aortic cannula were attached to an SD9 stimulator (Grass Instruments) delivering square wave pulses of 5-ms duration at 2-V amplitude.
Infarction Assessment in Isolated Murine Hearts
After retrograde perfusion commenced, the hearts were stabilized for 30 minutes. For inclusion, all hearts had to fulfill the following criteria: coronary flow between 1.5 and 4.5 mL/min, heart rate Ͼ300 bpm (unpaced), left ventricular developed pressure Ͼ55 mm Hg, time from thoracotomy to aortic cannulation Ͻ3 minutes, and no persistent dysrhythmia during stabilization. All hearts then underwent 30 minutes of global ischemia by clamping the aortic inflow tubing, followed by 2 hours of reperfusion. Electrical pacing was stopped when contraction ceased during ischemia and restarted 30 minutes into reperfusion. In hearts pretreated with SB203580 (Sigma), the agents were dissolved in Krebs buffer and perfused for 10 minutes before 30 minutes of global ischemia.
After 2 hours of reperfusion, hearts were perfused for 1 minute with 5 mL of 1% triphenyl tetrazolium chloride (TTC) in PBS and then placed in an identical solution at 37°C for 10 minutes. The atria were then removed, and the hearts were blotted dry, weighed, and stored at Ϫ20°C for up to 1 week. Hearts were then thawed, placed in 2.5% glutaraldehyde for 1 minute, and set in 5% agarose. The agarose heart blocks were then sectioned from apex to base in 0.7-mm slices using a vibratome (Agar Scientific). After sectioning, slices were placed overnight in 10% formaldehyde at room temperature before transferring into PBS for an additional day at 4°C. Sections were then compressed between Perspex plates (0.57 mm apart) and imaged using a TK-1280E digital camera (JVC). After magnification (ϫ25), planimetry was carried out using image analysis software (NIH image v1.61 and Adobe Photoshop 4.0) and surface area of the whole, and TTC-negative, left ventricular myocardium was transformed to volume by multiplication with tissue thickness. Within each heart, after summation of individual slices, TTC-negative infarction volume was expressed as a percentage of, or plotted against, left ventricular volume.
Western Blot Analysis
Samples were obtained from the mouse hearts at 5, 10, or 20 minutes of ischemia and after perfusion with 5 ng/mL of TNF (Sigma) for 7 or 15 minutes, 25 mol/L of peroxynitrite (Calbiochem) for 15 minutes, 20 mol/L of anisomycin (Sigma) for 15 minutes, or 0.1 mol/L sorbitol (Sigma) for 15 minutes. Samples were also harvested from H9c2 monolayers after 3 hours of simulated ischemia (see below). Samples were then homogenized in electrophoresis sample buffer (250 mmol/L Tris-HCl, 4% SDS, 10% glycerol, and 2% ␤-mercaptoethanol, pH 6.8). After transfer, equal loading on nitrocellulose membranes was confirmed by staining with Ponceau-S. After blocking with 5% nonfat milk, nitrocellulose membranes were exposed to the following primary antibodies: anti-dual phospho-p38 MAP kinase (Thr 180 and Tyr 182 ) (Sigma) at 1:1000, anti-p38 at 1:1000, anti-HSP27 at 1:1000, anti-MKK3/6 at 1:1000, and antiphospho MKK3/6(Ser 189 /Ser 207 ) at 1:500 (all from Santa Cruz Biotechnology), anti-TAB1 at 1:500 (Active Motif or Santa Cruz Biotechnology) and anti-phospho-HSP27(Ser 83 ) at 1:400, 1 before appropriate second antibody and ECL detection (Amersham). Autophotographic images of the Western blots were scanned and then quantified using NIH image analysis software.
Adenoviral Construction and Transfection of H9c2 Myoblasts
Our rationale, methods of adenovirus construction, amplification, and infection have been described previously. 1, 3 The culture and simulation of ischemia are also as described previously. 1
Immunoprecipitation
Hearts were homogenized in 0.75 mL of iced immunoprecipitation buffer (20 mmol/L HEPES, 1 mmol/L EDTA, 150 mmol/L NaCl, 1 mmol/L DTT, 5 mmol/L NaF, 1 mmol/L Na 3 VO 4 , one protease inhibitor tablet per 50 mL [Complete, Roche, Germany], 1% Triton X-100) per 100 mg of wet tissue. Homogenized tissue was centrifuged (10 000g, 15 minutes, 4°C), and supernatant (200 L) was incubated with 15 L of protein G slurry (Protein G PLUS-Agarose, Santa Cruz Biotechnology) for 1 hour at 4°C to preclear the sample. After additional centrifugation for 10 minutes at 4°C, supernatants were incubated with 30 L of agarose-conjugated anti-p38 MAPK antibody (Santa Cruz Biotechnology) and agitated for 2 hours at 4°C. Samples were then recentrifuged (10 000g, 5 minutes, 4°C) and the supernatant stored for additional analysis (lysate). Pellets were washed and resuspended three times in immunoprecipitation buffer and then finally resuspended in 30 L of SDS sample buffer and boiled for 3 minutes. The samples were centrifuged (10 000g, 5 minutes, 4°C), and the supernatants were kept for Western blotting (immunoprecipitate).
Statistical Analysis
All data are presented as meanϮSEM. Hemodynamic variables were compared between groups by 2-way repeated-measures ANOVA with a multivariate linear model to correct for the differing group sizes. An unpaired t test was used to test for differences in normalized infarct volume between two groups. Linear regression was carried out using the SigmaStat statistical package, whereas infarction volume with respect to total myocardial volume was compared by ANCOVA using an Excel plug-in (Ferris State University). PϽ0.05 was considered significant.
Results mkk3 ؊/؊ Hearts
The mkk3 Ϫ/Ϫ mice did not differ obviously from the mkk3 ϩ/ϩ mice. Specifically, their body mass, heart mass, and baseline and postischemic left ventricular developed pressure and coronary flows were similar (see the online Table, available in the online data supplement at http://www.circresaha.org). We have found that 30 minutes of global ischemia results in infarction of 30% to 65% of the left ventricular volume. Our expectation was that this distribution of infarction volume would differ in mkk3 Ϫ/Ϫ versus mkk3 ϩ/ϩ hearts. In Figure 1A , it is apparent that the normalized infarction volume does not differ by genotype. To be certain that this is not a function of the nonzero intercept between infarction and ventricular volumes, 15 these are plotted separately ( Figure 1B) , demonstrating similar lines of identity for each genotype.
There are two possible explanations for this counterintuitive finding. The first is that intraischemic p38-MAPK activation is deficient in mkk3 Ϫ/Ϫ hearts but that this had no impact on sensitivity to ischemia. The second is that p38-MAPK activation is unaltered by the absence of MKK3. We therefore measured p38-MAPK activation by probing the phosphorylation status of the key tyrosine and threonine residues within the activation lip that are the targets of the dual-specificity kinase MKK3. 14 The pattern of p38-MAPK dual phosphorylation in isolated mkk3 ϩ/ϩ and mkk3 Ϫ/Ϫ hearts is shown in Figure 2 . Although there is a 4-fold increase in p38-MAPK activation during ischemia, this is not blunted in the mkk3 Ϫ/Ϫ hearts (see Figure 2B ). Furthermore, this preservation in activation is not the result of a compensatory increase of the other MKK upstream of p38-MAPK, MKK6. The MKKs are in turn activated by phosphorylation by upstream MKKKs such as ASK1. 16 Although we probed for one of these sites of activation (Ser 189 /Ser 207 ) within MKK3/6, we were never able to detect a strong signal (see phospho-MKK3/6 lane in Figures 2 and 3) . Nonetheless it seems that MKK3 is preferentially activated over and above MKK6 by ischemia, with no detectable phospho-MKK3/6 signal in mkk3 Ϫ/Ϫ hearts. This is surprising, because although MKK4 can activate p38-MAPK in vitro, MKK3 and MKK6 are thought to be the only physiologically relevant activators of p38-MAPK in the intact cell. 17 Thus, the dual phosphorylation of p38-MAPK seems unaltered in the mkk3 Ϫ/Ϫ hearts despite the absence of an active upstream MKK.
Effects of SB203580
The phosphorylation of p38-MAPK in the absence of detectable activation of an upstream MKK could be the result of autophosphorylation. 18 Figure 3 shows the pattern of intraischemic p38 activation in C57B/6 hearts in the presence and absence of preischemic and intraischemic exposure to the p38-MAPK catalytic site inhibitor, SB203580 (1mol/L). Trapping SB203580 in the myocardium during zero-flow ischemia abolishes p38-MAPK activation and downstream HSP27 phosphorylation. In contrast to MKK3 deficiency, this intervention is associated with a reduction in normalized infarction volume and a downward shift in the relationship between infarction and total left ventricular volume ( Figures 1A and 1B, right) The MKK3 independence of this effect is confirmed by the fact SB203580 similarly reduces infarction on the mkk3 Ϫ/Ϫ background ( Figures  1A and 1B, left) . In addition, although the ischemic activation of p38-MAPK occurs in MKK3-deficient hearts, it is still abolished by SB203580 ( Figure 4C) Thus, in contrast to the absence of detectable MKK3/6 activation seen in the mkk3 Ϫ/Ϫ hearts, SB203580 diminishes both p38-MAPK activation and infarction volume. The question is whether this mechanism of MKK-independent activation is common to other archetypal activators of myocardial p38-MAPK.
Mechanism of TNF-Induced p38-MAPK Activation
TNF is known to activate p38-MAPK in numerous cell types. 19 Within the heart, this cytokine is thought to be involved in an amplifying autocrine/paracrine loop that leads to cachexia and worsening cardiac performance in chronic heart failure. 20 We therefore examined the ability of intracoronary TNF at a concentration of 5 ng/mL to activate myocardial p38-MAPK.
At 15 minutes but not 7 minutes of exposure, there was robust activation of p38-MAPK. Figure 4A shows that the activation at 15 minutes is unaltered by coincident SB203580 at a concentration that abolishes ischemia-induced activation of p38-MAPK (compare with Figure 4B ) and inhibits catalytic activity, because downstream HSP27 phosphorylation is inhibited. Moreover, in the MKK3-deficient hearts, this TNF-induced activation is absent ( Figure 4A) . Thus, the pattern of TNF-induced activation is SB-independent but MKK3-dependent, whereas that during ischemia is SBdependent but MKK3-independent.
Confirming Sensitivity to SB203580 as an Index of Autophosphorylation
SB203580 is known to inhibit a variety of kinases in addition to p38-MAPK. [21] [22] [23] [24] Thus, it is possible that our observations are the result of SB203580 inhibiting a kinase upstream of p38-MAPK that is activated by ischemia but not TNF. To exclude this possibility, we expressed wild-type and mutant forms of p38␣-MAPK in H9c2 cells. The mutation, where Thr 106 , His 107 , and Leu 108 have been changed to Met, Pro, and Phe, respectively (T106M, H107P, and L108F), has been Figure 2) is absent in the presence of SB203580. B, Quantitative data derived from 3 separate series of experiments that confirms the abolition of p38-MAPK phosphorylation by SB203580. As in Figure 2 , only one band is detected during ischemia with the anti-phospho MKK3/6 antibody, and this not influenced by the presence of SB203580 in contrast to the phospho p38-MAPK signal. constructed, studied, and shown to have effects in vivo and in vitro that are indistinguishable from wild-type p38␣-MAPK. 25 However, in contrast to wild-type p38␣-MAPK, the triple mutant is inherently resistant to SB203580 in the same manner as the p38␦-MAPK and p38␥-MAPK isoforms, which share the 106M, 107P, and 108F consensus. 26 We have previously shown that p38␣-MAPK is activated in response to ischemia in H9c2 cells and that this contributes to injury. 1 In Figure 5 , we confirm that wild-type p38␣-MAPK is activated during simulated ischemia, and this is associated with phosphorylation of HSP27; both of these changes are usually inhibited by SB203580. In contrast, although these ischemia-induced changes occur with the SB203580-resistant form of p38␣-MAPK (DR), they can no longer be inhibited. These findings confirm the action of SB203580 is dependent on its ability to bind to the catalytic domain of p38␣-MAPK.
Association of p38-MAPK With TAB1
TAB1 is a scaffold protein that binds components of a transforming growth factor-␤-initiated signal transduction cascade, including p38-MAPK, where its binding promotes p38-MAPK autophosphorylation. 18 Homogenates were prepared from hearts subjected to 10 minutes of global ischemia or 15 minutes of TNF, conditions causing p38-MAPK activation ( Figure 4 ). Under both of these circumstances, a significant portion of immunoprecipitated total p38-MAPK was dual-phosphorylated, but the association with TAB1 was restricted to ischemia (see Figure 6 and legend for fuller explanation).
Our data, in keeping with those of Ge et al, 18 suggest that the mechanisms leading to phosphorylation of p38 MAP kinase can differ according to stimulus. However, Ge et al found that p38-MAPK phosphorylation in HEK293 cells exposed to TNF was SB203580-sensitive. Accordingly, we examined whether other differences existed in the mode of p38-MAPK activation between HEK293 cells and the murine heart. We studied the archetypal p38-MAPK activating stresses adopted by Ge et al 18 and examined the sensitivity to SB203580 and association with TAB1. Infusion of peroxynitrite and anisomycin resulted in marked, and sorbitol resulted in less marked, phosphorylation of p38-MAPK. This phosphorylation was completely, partially, and negligibly inhib- . MKK3-and SB203580-dependence of TNF-versus ischemia-induced p38-MAPK activation. TNF was infused at a concentration of 5 ng/mL in oxygenated K-H buffer (A). Hearts were harvested at 10 minutes of ischemia (B). (1) and (2) relate to separate series of experiments. The robust dual phosphorylation of p38-MAPK caused by TNF (A) was unaltered by the presence of SB203580 at a concentration that inhibited ischemia-induced activation (B). However, TNF-induced activation was abolished in the MKK3-deficient hearts (A), whereas this had no effect on ischemia-induced activation (B). Although SB203580 had no effect on TNF-induced p38-MAPK phosphorylation, it did inhibit catalytic activity, because downstream HSP27 phosphorylation was abolished. TNF causes a shift in JNK phospho-forms, which is unchanged in the absence of MKK3. This implies that TNF-initiated signals to one MAPK are intact (JNK), whereas to another they are absent (p38-MAPK). Thus, it is unlikely that the absence of MKK3 causes a generalized defect in TNF response. C, Activation of p38-MAPK after 10 minutes of global ischemia in MKK3-deficient hearts is sensitive to SB203580. Figure 5 . p38-MAPK phosphorylation during simulated ischemia in the presence and absence of SB203580 in H9c2 cells expressing SB203580-sensitive (WT) and -resistant (DR) forms of p38␣-MAPK. The total p38 signal is strong because of virally mediated overexpression. The DR form of p38-MAPK has T106M, H107P, and L108F substitutions (see Results for details) that prevent SB203580 binding but not ATP binding. Ischemia causes phosphorylation of both the WT and DR forms of p38-MAPK, which is prevented by SB203580 only in WT. This signifies that the action of SB203580 is attributable to the inhibition of the catalytic activity of p38-MAPK on which p38-MAPK dual phosphorylation depends. This observation suggests that p38-MAPK activation during simulated ischemia is by autophosphorylation. In 4 independent experiments, SB203580 reduced dual phosphorylation of WT p38-MAPK by 49Ϯ16% and DR p38-MAPK by 4Ϯ3%, PϽ0.05.
ited with SB203580, respectively ( Figure 7A ). TAB1 was only strongly associated with p38 MAP kinase in peroxynitrite-and anisomycin-exposed hearts ( Figure 7B ).
Discussion
Our findings suggest that during global ischemia p38-MAPK becomes activated and that this contributes to necrosis of the isolated murine heart. Surprisingly, the mode of p38-MAPK activation seems independent of upstream MKKs but depends instead on an SB203580-sensitive mechanism of activation, which is associated with binding to TAB1. This pattern contrasts with the mode of activation by TNF and raises the possibility that a deeper understanding of this diversity may lead to ischemia-selective interventions.
The Likely p38-MAPK Isoform and Mechanisms of Activation
It is probable that in the present study the major endogenous SB-sensitive p38-MAPK isoform is p38␣, because in rodent myocardium it is likely that the p38␣ isoform dominates. For example, Wang and colleagues 13 were unable to detect the ␤ isotype in murine myocardium, and we were unable to detect it in rat myocardium. 27 The same p38␣ preponderance also seems to occur in human myocardium. 28 The traditional mechanism of p38-MAPK activation is by transphosphorylation of the activation lip by upstream MKKs. Because SB203580 occupies the ATP-binding pocket within the kinase cleft, 26 it should only inhibit phosphorylation events downstream of p38-MAPK and not the phosphorylation of p38-MAPK itself. This view was challenged by the recent observations by Ge et al, 18 who draw attention to previously published reports where SB203580 does inhibit p38-MAPK phosphorylation and show this is probably the result of circumstance-specific autophosphorylation of p38␣-MAPK. In the cardiac literature, it is also possible to find similar instances of SB203580-sensitive phosphorylation of p38-MAPK, including during myocardial ischemia (lane 4 of Figure 2 in the study by Maulik et al 29 ) . However, these observations may also result from the nonspecific profile of SB203580 causing the inhibition of a kinase upstream of p38-MAPK but not direct MKK inhibition 18 and thereby reducing its transphosphorylation rather than autophosphorylation. However, Ge et al 18 show that phosphorylation under these circumstances is dependent on intramolecular kinase Figure 6 . The interaction between p38-MAPK and TAB1 during ischemia and with TNF. Whole hearts exposed to 10 minutes of global ischemia or 15 minutes of TNF were homogenized and total p38-MAPK immunoprecipitated (IP). A positive control for TAB1 was prepared from HEK293 cells transfected with fulllength human TAB1 (1-504) cDNA obtained from Dr Jiahuai Han, 18 The Scripps Research Institute, La Jolla, Calif. Equal loading is confirmed by immunoblotting (WB) precipitates with anti-p38-MAPK. TNF and ischemia increase the proportion of dual phosphorylated p38-MAPK. Although the positive control has not been subjected to immunoprecipitation, transfection with TAB1 did cause p38-MAPK activation (data not shown). TAB1 only associates with p38-MAPK in hearts subjected to global ischemia, although similar p38-MAPK activation occurred within the precipitate from TNF-exposed hearts. The presence of excess TAB1 is confirmed in all samples by immunoblotting of the lysate. The larger apparent molecular weight of TAB1 in the positive control is the result of species differences confirmed by immunoblotting of crude mouse heart homogenates and solubilized protein from a human cell line. Figure 7 . p38-MAPK phosphorylation in hearts exposed to peroxynitrite, anisomycin, and sorbitol. Agents were perfused intracoronary (see text for additional details) at concentrations that caused less than a 50% decline in contractility or flow. Dual phosphorylation in response to peroxynitrite and anisomycin is at least partially sensitive to SB203580 (A). Those agents that cause SB203580-sensitive phosphorylation of p38-MAPK result in an association with TAB1 (B). Experimental conditions for immunoprecipitation are identical to Figure 6 . activity excluding transphosphorylation by another kinase or p38␣-MAPK molecule. Moreover, this form of activation is related to an association with the scaffold protein TAB1. Similarly, in this study we show that the reduction in activation loop phosphorylation caused by SB203580 is unlikely to be attributable to nonspecific inhibition of another kinase, because it is dependent on its ability to bind p38␣-MAPK. However, this reduction may be cell-type specific, because Ge et al 18 found p38-MAPK activation in response to TNF was SB-sensitive whereas we did not. However, the findings with peroxynitrite, anisomycin, and sorbitol exposure are more consistent across the studies. Our findings with TNF are limited to the whole heart, whereas the findings by Ge et al 18 were confined to HEK 293 cells. Furthermore, our findings are consistent with those of Wysk et al, 11 who also found TNF-induced p38-MAPK activation was MKK3dependent in murine fibroblasts.
Consequence of p38 Activation by Transphosphorylation or Autophosphorylation
At present, it is not clear how the signals immediately upstream of p38-MAPK diverge to enable different mechanisms of activation. It is possible for example that an alternative p38-MAPK kinase other than MKK3 is responsible for the activation during ischemia. Furthermore, our observations in the whole heart could be explained if this unidentified kinase were sensitive to SB203580 and TAB1associated. To counter this possibility, we present in vitro data in a myoblast line with adenovirus-driven expression of SB-sensitive and SB-resistant forms of p38␣-MAPK. Although this system may not faithfully recapitulate the mechanisms of p38-MAPK activation in the ischemic heart, the different patterns of sensitivity to SB203580 and the absence of MKK3 must indicate divergence of upstream signals. Although speculative, it is likely that these different mechanisms of activation exist, because their downstream consequences differ. Thus, although TNF and ischemia activate p38-MAPK, signaling specificity maybe conferred by the circumstances of activation. 30 Such subtleties may partly explain the diverse consequences of p38-MAPK activation reported that depend on model, ischemic conditions, and species. 2 Furthermore, they may allow additional dissection of the pleiotropic responses to TNF that are frustrating clinical development of anti-TNF therapies for heart failure. 30, 31 In conclusion, we show that different mechanisms contribute to myocardial p38-MAPK activation during ischemia and TNF exposure. Our findings suggest that during ischemia, autophosphorylation is responsible for a form of activation that has detrimental consequences. At present, it is unclear whether the nature of activation occurring with TNF has similar consequences. 32, 33 
